Fetal valproate spectrum disorder

Fetal valproate spectrum disorder (FVSD), also known as fetal valproate syndrome or valproate embryopathy, is a pattern of congenital malformations and neurodevelopmental difficulties that can occur in children exposed to the antiepileptic drug valproic acid (sodium valproate) during pregnancy. It is not an inherited genetic condition but rather a teratogenic disorder caused by in utero drug exposure. The condition affects multiple body systems and is characterized by a distinctive facial appearance (including a thin upper lip, broad nasal bridge, epicanthic folds, small upturned nose, and a long smooth philtrum), neural tube defects (particularly spina bifida), congenital heart defects, skeletal anomalies (such as radial ray defects and overlapping digits), urogenital malformations, and growth delays. Neurodevelopmental effects are a major component of the spectrum and may include intellectual disability, autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), speech and language delays, and difficulties with social communication and executive function. These cognitive and behavioral challenges can occur even in the absence of major structural malformations. The severity of the condition is variable and appears to be dose-dependent, with higher doses of valproate during pregnancy associated with greater risk. There is no cure for fetal valproate spectrum disorder, and management is supportive and multidisciplinary. Treatment focuses on addressing individual clinical features, including surgical correction of congenital malformations where appropriate, early intervention programs for developmental delays, speech and occupational therapy, educational support, and behavioral management. Prevention is the most important strategy, and current medical guidelines strongly recommend that women of childbearing potential avoid valproate use whenever possible, or use effective contraception if no alternative treatment is available.

Common questions about Fetal valproate spectrum disorder